The expression of IL-6 and STAT3 might predict progression and unfavorable prognosis in Wilms’ tumor

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger, Andrew J. Rowan, Stuart Horswell et al. · New England Journal of Medicine · 2012 · 7.8K citations · Full text

Medicine, Cancer Biology, Oncology +14

Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?

Sergei I. Grivennikov, Michael Karin · Cancer Cell · 2008 · 369 citations · Full text

Life Sciences, Cancer Biology, Immunology +10

Interleukin‐6 predicts recurrence and survival among head and neck cancer patients

Sonia A. Duffy, Jeremy M. G. Taylor, Jeffrey E. Terrell et al. · Cancer · 2008 · 332 citations · Full text

Medicine, Immunology, Oncology +15

Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer

Sharon R. Pine, Leah E. Mechanic, Lindsey Enewold et al. · JNCI Journal of the National Cancer Institute · 2011 · 330 citations

Medicine, Immunology, Oncology +17

Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer

Tanya B. Dorff, Bryan Goldman, Jacek Pinski et al. · Clinical Cancer Research · 2010 · 214 citations · Full text

Medicine, Oncology, Pharmacotherapy +17